GlassScriptPhysician profile
Margarette R Recalde
NPI 1972695500
$44,385.34
in general payments reported to CMS, 2019-2025
28 companies · $1,641 in 2025
The $1,641 reported for 2025 was more than what 96% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $9,913 · 2020: $4,381 · 2021: $3,741 · 2022: $18K · 2023: $4,981 · 2024: $1,477 · 2025: $1,641.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,661 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $3,360 · Consulting Fee: $750 · Entertainment: $283 · Education: $45.13.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,661.38 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $3,360.00 |
| Consulting Fee | $750.00 |
| Entertainment | $282.90 |
| Education | $45.13 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sun Pharmaceutical Industries INC. | $17,179.68 | 2019-2025 | Cequa, Xelpros, Bromsite |
| Oyster Point Pharma, INC. | $10,934.36 | 2022-2025 | Tyrvaya, Ryzumvi |
| Kala Pharmaceuticals, INC. | $4,190.64 | 2020-2022 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $3,292.45 | 2019-2021 | |
| Allergan, INC. | $1,365.47 | 2019-2022 | |
| Alcon Vision LLC | $1,353.86 | 2021-2025 | Precision 1, Precision7, Tryptyr |
| Tarsus Pharmaceuticals, INC. | $931.16 | 2024-2025 | Xdemvy |
| Coopervision INC. | $922.31 | 2019-2025 | Myday Contact Lens, Misight Contact Lens |
| Optos, INC. | $644.52 | 2019-2025 | Oct Ophthalmoscope, Panoramic Ophthalmoscope, Nfc-700 |
| Bausch & Lomb Americas INC. | $636.37 | 2022-2025 | Infuse, Miebo, Xiidra |
| Glaukos Corporation | $590.09 | 2021-2025 | Kxl System (Not Refurbished), Kxl1b-Ce-Marked Kxlsystem, Istent Inject Trabecular Micro-Bypass System Model G2-M-Is |
| Dompe US, INC. | $535.22 | 2019-2025 | Oxervate |
| Sight Sciences, INC. | $326.82 | 2019-2025 | Tearcare System |
| Johnson & Johnson Vision Care, INC. | $280.24 | 2019-2024 | Acuvue |
| Topcon Healthcare, INC. | $241.40 | 2021-2023 |
Show all 28 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Aerie Pharmaceuticals, INC. | $147.55 | 2019-2020 | |
| Biotissue Holdings INC. | $146.34 | 2019-2024 | |
| Maculogix, INC. | $126.81 | 2019 | |
| Novartis Pharmaceuticals Corporation | $126.50 | 2019-2023 | |
| Immunogen, INC. | $124.99 | 2023 | Elahere |
| Lkc Technologies, INC. | $110.02 | 2024 | |
| Abbvie INC. | $58.57 | 2022 | |
| Eyevance Pharmaceuticals LLC | $33.40 | 2021-2022 | |
| Harrow Eye, LLC | $24.79 | 2025 | Vevye |
| Carl Zeiss Meditec Ag | $19.40 | 2020 | |
| Carl Zeiss Meditec, INC. | $16.12 | 2020 | |
| Mallinckrodt Hospital Products INC. | $14.04 | 2021 | |
| Shire North American Group INC | $12.22 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Margarette Recalde listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.